Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70


Caval seminoma thrombus on FDG PET/CT.

Koc K, Aras M, Inanir S.

Rev Esp Med Nucl Imagen Mol. 2015 Jan-Feb;34(1):64-5. doi: 10.1016/j.remn.2014.01.004. Epub 2014 Mar 1. No abstract available.


Can we rely on PET in the follow-up of advanced seminoma patients?

Siekiera J, Małkowski B, Jóźwicki W, Jasiński M, Wronczewski A, Pietrzak T, Chmielowska E, Petrus A, Kamecki K, Mikołajczak W, Kraśnicki K, Chłosta P, Drewa T.

Urol Int. 2012;88(4):405-9. doi: 10.1159/000337056. Epub 2012 Apr 12.


FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals.

Becherer A, De Santis M, Karanikas G, Szabó M, Bokemeyer C, Dohmen BM, Pont J, Dudczak R, Dittrich C, Kletter K.

Eur J Radiol. 2005 May;54(2):284-8.


18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus?

Sharma P, Kumar R, Jeph S, Karunanithi S, Naswa N, Gupta A, Malhotra A.

Nucl Med Commun. 2011 Sep;32(9):782-8. doi: 10.1097/MNM.0b013e32834774c8.


18F-FDG PET/CT impact on testicular tumours clinical management.

Ambrosini V, Zucchini G, Nicolini S, Berselli A, Nanni C, Allegri V, Martoni A, Rubello D, Cricca A, Fanti S.

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):668-73. doi: 10.1007/s00259-013-2624-3. Epub 2013 Nov 22. Erratum in: Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):585. Domenico, Rubello [corrected to Rubello, Domenico].


2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.

De Santis M, Becherer A, Bokemeyer C, Stoiber F, Oechsle K, Sellner F, Lang A, Kletter K, Dohmen BM, Dittrich C, Pont J.

J Clin Oncol. 2004 Mar 15;22(6):1034-9.


2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.

Bachner M, Loriot Y, Gross-Goupil M, Zucali PA, Horwich A, Germa-Lluch JR, Kollmannsberger C, Stoiber F, Fléchon A, Oechsle K, Gillessen S, Oldenburg J, Cohn-Cedermark G, Daugaard G, Morelli F, Sella A, Harland S, Kerst M, Gampe J, Dittrich C, Fizazi K, De Santis M.

Ann Oncol. 2012 Jan;23(1):59-64. doi: 10.1093/annonc/mdr052. Epub 2011 Apr 2.


FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment.

Quak E, Kovacs I, Oyen WJ, van der Graaf WT.

Nucl Med Mol Imaging. 2015 Sep;49(3):237-40. doi: 10.1007/s13139-015-0321-9. Epub 2015 Feb 13.


Tumor thrombus in the inferior vena cava from colon cancer detected by 18F-FDG-PET.

Kaida H, Ishibashi M, Kurata S, Uchida M, Hayabuchi N.

Ann Nucl Med. 2007 Jun;21(3):185-8.


Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: systematic review and meta-analysis.

Treglia G, Sadeghi R, Annunziata S, Caldarella C, Bertagna F, Giovanella L.

Biomed Res Int. 2014;2014:852681. doi: 10.1155/2014/852681. Epub 2014 May 15. Review.


FDG PET for detection and therapy control of metastatic germ cell tumor.

Cremerius U, Effert PJ, Adam G, Sabri O, Zimmy M, Wagenknecht G, Jakse G, Buell U.

J Nucl Med. 1998 May;39(5):815-22.


18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus.

Hara T, Truelove J, Tawakol A, Wojtkiewicz GR, Hucker WJ, MacNabb MH, Brownell AL, Jokivarsi K, Kessinger CW, Jaff MR, Henke PK, Weissleder R, Jaffer FA.

Circulation. 2014 Sep 23;130(13):1044-52. doi: 10.1161/CIRCULATIONAHA.114.008902. Epub 2014 Jul 28.


Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.

De Santis M, Bokemeyer C, Becherer A, Stoiber F, Oechsle K, Kletter K, Dohmen BM, Dittrich C, Pont J.

J Clin Oncol. 2001 Sep 1;19(17):3740-4. Erratum in: J Clin Oncol 2001 Dec 1;19(23):4355.


Incidental diagnosis of thrombus within an aneurysm on 18F-FDG PET/CT: frequency in 926 patients.

Muzaffar R, Kudva G, Nguyen NC, Osman MM.

J Nucl Med. 2011 Sep;52(9):1408-11. doi: 10.2967/jnumed.111.091264. Epub 2011 Aug 4.


Extensive tumor thrombus in a case of carcinoma lung detected by F18-FDG-PET/CT.

Mudalsha R, Jacob M, Pandit A, Jora C.

Indian J Nucl Med. 2011 Apr;26(2):117-9. doi: 10.4103/0972-3919.90269.


[Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].

Pfannenberg AC, Oechsle K, Kollmannsberger C, Dohmen BM, Bokemeyer C, Bares R, Vontheim R, Claussen CD.

Rofo. 2004 Jan;176(1):76-84. German.


Diagnostic accuracy of 18F-FDG-PET in patients with testicular cancer: a meta-analysis.

Zhao JY, Ma XL, Li YY, Zhang BL, Li MM, Ma XL, Liu L.

Asian Pac J Cancer Prev. 2014;15(8):3525-31.


¹⁸F FDG PET/CT demonstration of IVC and right atrial involvement in adrenocortical carcinoma.

Senthil R, Mittal BR, Kashyap R, Bhattacharya A, Radotra BD, Bhansali A.

Jpn J Radiol. 2012 Apr;30(3):281-3. doi: 10.1007/s11604-011-0037-4. Epub 2011 Dec 17.

Items per page

Supplemental Content

Write to the Help Desk